Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2003 02:04 ET | Source: Celltech Group plc

Celltech Group plc Announces Interim Report for the Six Months Ended 30 June 2003

Slough, UK, August 19, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) Interim Report for the Six Months Ended 30 June 2003 As a leading European biotechnology company with a strong...
August 01, 2003 04:37 ET | Source: Celltech Group plc

Celltech Group plc: US Food and Drug Administration Approves Zavesca -- First Oral Treatment Option for Type 1 Gaucher Disease

SLOUGH, U.K., August 1, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) and Actelion Ltd (SWX:ATLN) today announced that the US Food and Drug Administration (FDA) has approved Zavesca(R)...
July 14, 2003 03:12 ET | Source: Celltech Group plc

Celltech Group plc: Celltech Announces Long-Term Microbial Manufacturing Agreement with Lonza

SLOUGH, England, July 13, 2003 (PRIMEZONE) -- Celltech Group plc (NYSE:CLL) (LSE:CCH) announced today that it has entered into a long-term supply agreement with Lonza Biotec, a division of Lonza...